NightWare
Hopkins, US · Delaware corporation · 1 known investors
NightWare is an FDA-cleared prescription digital therapeutic system designed to interrupt nightmares as they occur, improving sleep quality for patients with Nightmare Disorder, including those with PTSD. It is intended for physicians and patients seeking treatment for frequent, traumatic nightmares.
Digital HealthHealthtechMedical DevicesMental Health
Founders & leadership
MT
Matthew TuckerExecutive
GH
Grady HannahNamed on SEC filing
MN
Board
MO
Michael OttBoard director
GM
Gerald MattysBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 5 rounds · 2019–2026
▶$250KraisedMar 2026 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedMar 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Grady HannahDirector
- Matthew TuckerExecutive Officer, Director
- Gerald MattysDirector
- Richard NigonDirector
- Michael OttDirector
- Offering amount
- $2M
- Amount sold
- $250K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedSep 2025 · 18 investors · Other Health CareRule 506(b)
▶$1.1MraisedSep 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew TuckerExecutive Officer, Director
- Michael OttDirector
- Gerald MattysDirector
- Grady HannahDirector
- Offering amount
- $3M
- Amount sold
- $1.1M
- Sales commissions
- $139K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$700KraisedJul 2022 · 6 investors · Other Health CareRule 506(b)
▶$700KraisedJul 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Grady HannahExecutive Officer, Director
- Gerald MattysDirector
- Nathan MichaelExecutive Officer, Director
- Matthew TuckerExecutive Officer, Director
- Offering amount
- $4.5M
- Amount sold
- $700K
- Sales commissions
- $438K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedFeb 2021 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedFeb 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Grady HannahExecutive Officer, Director
- Nathan MichaelExecutive Officer, Director
- Matthew TuckerExecutive Officer, Director
- Tom VanderheydenDirector
- Offering amount
- $1.5M
- Amount sold
- $100K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$305KraisedMay 2019 · 8 investors · OtherRule 506(b)
▶$305KraisedMay 2019 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael NathanExecutive Officer, Director
- Grady HannahExecutive Officer, Director, Promoter
- Offering amount
- $2.8M
- Amount sold
- $305K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap(TIME)18 shared keywordsTIME is a global media brand, launched in 1923 as the first weekly news magazine, that publishes journalism across a website, print magazine, social channels, live events, and branded content. It also operates divisions and platforms spanning film and television, climate action, e-commerce recommendations, and NFTs, reaching an audience of over 100 million worldwide.
Steam15 shared keywordsSteam is a digital distribution platform for purchasing, downloading, and playing PC video games, operated by Valve. It serves gamers worldwide and offers a client application with multi-language support.
JustWatch10 shared keywordsJustWatch is a streaming guide platform that aggregates availability information for movies, TV shows, and sports across multiple streaming services. The service helps viewers find where content is available to watch and provides personalized recommendations based on their preferred platforms.
Companies competing with NightWare for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.2M |
| U.S. Air ForceAir Force | Phase IISTTR | 2022 | $749.7K |
| U.S. Air ForceAir Force | Phase ISTTR | 2022 | $50K |
| U.S. Air ForceAir Force | Phase I | 2021 | $49.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does NightWare do?
- NightWare is an FDA-cleared prescription digital therapeutic system designed to interrupt nightmares as they occur, improving sleep quality for patients with Nightmare Disorder, including those with PTSD. It is intended for physicians and patients seeking treatment for frequent, traumatic nightmares.
- Who are NightWare's investors?
- NightWare's investors include Exit 156 Capital.
- How much funding has NightWare raised?
- NightWare has disclosed $2.5M raised across 5 rounds.
- Where is NightWare headquartered?
- NightWare is headquartered in Hopkins, US.